manufacturing and geographies," said Zydus Lifesciences's Managing Director Sharvil Patel. The firm, dedicated to producing generic medications, has been broadening its product range to include ...

The acquisition aims to boost Zydus's global medtech ambitions, leveraging its expertise in life sciences. The deal includes a 81% premium over Amplitude Surgical's last closing price, aiming for ...

The proposed acquisition shall act as a platform to execute our global MedTech strategy and a natural extension for Zydus having a proven track record in life sciences and wellness segments ...

Zydus Lifesciences announced it is negotiating to acquire a majority stake in French medtech firm Amplitude Surgical for ...

Zydus Lifesciences Ltd. on Tuesday said it has entered into exclusive negotiations to acquire a majority stake in France-based Amplitude Surgical for €256.8 million. “The acquisition price ...

The stock of Zydus Lifesciences has been in a steady decline since August last year after facing resistance at ₹1,300. After witnessing some consolidation between ₹940 and ₹1,000 in December ...

(Reuters) -India's Zydus Lifesciences (ZYDUSLIFE.NS) said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical (AMPLI.PA) for 256.8 million euros (nearly $280 million) as part of ...

Zydus Lifesciences has entered exclusive negotiations to acquire a controlling stake in France-based medtech firm Amplitude Surgical SA for €256.8 million, the drugmaker said on Tuesday, as it ...

Zydus Lifesciences Ltd has received final approval from the United States Food and Drug Administration (USFDA) to produce the antifungal drug Ketoconazole Shampoo, 2%. The approval is valid for ...

Sharvil Patel, Managing Director, Zydus Lifesciences Ltd. (Image Credits ... and we do have global aspirations from being a life sciences organization. This plans helps us in terms of globalising ...